Ascent Industries Executive Shows Confidence with $50,000 Stock Purchase

Rhea-AI Filing Summary

Insider Trading Alert: Ravi Ramesh Srinivas, VP of Operations - Chemicals at Ascent Industries (ACNT), has increased his position by purchasing 4,000 shares of common stock on June 18, 2025. The shares were acquired at a weighted average price of $12.44 per share, with individual transaction prices ranging from $12.38 to $12.50.

Following this transaction, Srinivas now beneficially owns a total of 16,000 shares directly. The purchase demonstrates a significant insider investment of approximately $49,760. This Form 4 filing indicates increased insider confidence in the company's prospects.

• Transaction Type: Open market purchase
• Ownership Form: Direct ownership
• Filing Relationship: Officer (VP, Operations - Chemicals)
• No derivative securities were involved in this transaction

Positive

• VP of Operations - Chemicals purchased 4,000 shares at $12.44 average price, representing a 33% increase in holdings from 12,000 to 16,000 shares, demonstrating strong insider confidence

Negative

• None.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Srinivas Ravi Ramesh

(Last) (First) (Middle)

20 N. MARTINGALE RD

SUITE 430

(Street)

SCHAUMBURG IL 60173

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ASCENT INDUSTRIES CO. [ ACNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			VP, Operations - Chemicals

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		P		4,000	A	$12.44(1)	16,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $12.38 to $12.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth within this footnote.

Remarks:

	Ravi Ramesh Srinivas	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of ACNT stock did Ravi Ramesh Srinivas purchase on June 18, 2025?

Ravi Ramesh Srinivas, VP of Operations - Chemicals at Ascent Industries, purchased 4,000 shares of ACNT common stock on June 18, 2025.

What was the purchase price for ACNT shares in the June 18, 2025 insider transaction?

The shares were purchased at a weighted average price of $12.44 per share, with individual transaction prices ranging from $12.38 to $12.50 per share.

How many ACNT shares does Ravi Ramesh Srinivas own after the June 18, 2025 purchase?

Following the reported transaction, Ravi Ramesh Srinivas directly owns 16,000 shares of ACNT common stock.

What is Ravi Ramesh Srinivas's position at ACNT?

Ravi Ramesh Srinivas serves as VP, Operations - Chemicals at Ascent Industries Co. (ACNT).

Was this ACNT insider purchase made under a 10b5-1 trading plan?

No, the Form 4 filing does not indicate that this transaction was made pursuant to a Rule 10b5-1 trading plan, as the corresponding checkbox was not marked.